Validation and reliability of the Malay version of the painDETECT questionnaire (PDQ-M) among patients with neuropathic and nociceptive pain [2024] - 373KB
by Huai Heng Loh, Anne Yee, Shanty Velaiutham, Zanariah Hussein, Mohamad Zaki Haji Mohd Amin, Sharifah Aishah Wan, Chin Voon Tong, Chun Yang Sim, Lorietta John, Florence Hui Sieng Tan, Mafauzy Mohamed
Background: Neuropathic pain is chronic and debilitating. Early and accurate diagnosis is important for appropriate management. The painDETECT questionnaire (PDQ) is an effective screening tool for pr...

Incidence and risk factors of cognitive impairment in COVID-19 survivors within the first six months and its association with functional outcome [2024] - 472KB
by Darwinus Lajim, Mazlina Mazlan, Sa’adah Muhamad Amin, Anwar Suhaimi
Background & Objective: There is growing evidence of cognitive decline post-COVID-19, even in mild infection. We aim to evaluate the incidence of cognitive impairment, domains affected, its risk facto...

Correlation of MRI brain findings with executive dysfunction and vascular risk factors in elderly patients with cognitive impairment [2024] - 479KB
by Bhawna Sharma, Mitul Kasundra
Objectives: The primary objective of the present study was to investigate the relationship between gray matter changes, white matter changes and executive function among older Indian adults with vascu...

Exploration of a comprehensive index for predicting cognitive impairment in patients with cerebral small vessel disease and white matter lesions [2024] - 478KB
by Weifu Zhang, Yu Cui, Rongguo Wang, Chenglong Liu, Ying Wang, Hongyan Xie
Background & Objective: The objective of this study was to explore the risk factors for cognitive impairment in patients with cerebral small vessel disease (CSVD), and to construct a predictive model ...

Predictors of caregiver burden in Alzheimer’s disease: Caregiver stress, life satisfaction and quality of life levels [2024] - 406KB
by Alime Selçuk Tosun, Neslihan Lök, Kerime Bademli
Objective: The purpose of this study was to determine the impact of socio-demographic and health characteristics, caregiving stress, life satisfaction, and quality of life on the caregiving burden in ...

Associations between the Framingham Risk Score and cognitive functions in people with multiple sclerosis [2024] - 404KB
by Alevtina Ersoy, Senanur Baloglu, Ceyda Tanoglu, Serhat Hayme
Background & Objective: Cognitive impairment is common in people with multiple sclerosis (MS). The Framingham Risk Score (FRS) is an algorithm used to estimate the 10-year risk of developing cardiovas...

Exploring the experience of multiple sclerosis patients in Turkey: Insights from a national survey [2024] - 304KB
by Melih Tütüncü, Serkan Demir, Tuncay Gündüz, Kamil Mavi, Çağcan Ölmez, Fatih İğde, Cihat Uzunköprü, Ali Özhan Sıvacı, Sıla Usar İncirli, Damla Çetinkaya Tezer, Haluk Gümüş, İpek Güngör Doğan, Bilge Piri Çınar, Sena Destan Bünül, Meral Seferoğlu, Ayşe Sağdu
Objective: To evaluate sociodemographic profile, clinical characteristics, disability and treatment status of multiple sclerosis (MS) patients in Turkey with respect to patient perspectives and expect...

Investigation of the effects of IL-13 and IL-22 cytokine levels on disease activity, prognosis, and treatment response in multiple sclerosis patients treated with fingolimod and glatiramer acetate [2024] - 416KB
by Fidel Demir, Deniz Evrim Kavak, Fırat Karaaslan, Mehmet Ufuk Aluçlu, Sevgi Irtegun Kandemir
Background: Multiple Sclerosis (MS) is an inflammatory, demyelinating and neurodegenerative disease. In this study, we investigated serum protein levels of Interleukin-13 (IL-13) and Interleukin-22 (I...

The evaluation of neurologists’ awareness on hepatitis B virus reactivation before launching immunosuppressive treatment [2024] - 407KB
by Arzu Tarakci, Esma Eroglu, Aysegul Demir
Background: Individuals encountering hepatitis B virus (HBV) are at risk of hepatitis B virus reactivation (HBVr) when exposed to immunosuppressive (IS) therapy. Here, we aimed to evaluate neurologist...

Efficacy of acetylcholinesterase inhibitors for cognitive impairment in multiple sclerosis: A systematic review and meta-analysis [2024] - 589KB
by Melmar C Folloso, Joseree-Ann S Catindig, Lovelle G Ditucalan, Steven G Villaraza, Ma Lourdes C Joson, Encarnita R Ampil
Background & Objective: Multiple Sclerosis (MS) is a chronic demyelinating condition characterized by a myriad of neurologic deficits. The prevalence rate of Cognitive impairment (CI) ranges from 40 t...